Friday, September 16, 2016

EMA panel recommends nod for Pfizer's breast cancer drug

… . drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given … is also testing an experimental breast cancer pill which belongs to same …

No comments:

Post a Comment